Cancer Immunotherapy Drug Discovery Outsourcing

World Market Report

MCP21411

EXECUTIVE ENGAGEMENTS

POOL

782
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

156
Interactions with Platform & by Email

PARTICIPANTS

31
Unique # Participated

VALIDATIONS

13
Responses Validated*

COMPANIES

34
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

22

PAGES

89

EDITION

4

PRICE

USD 5600

CODE

MCP21411


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Cancer Immunotherapy Drug Discovery Outsourcing Market to Reach $2.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Cancer Immunotherapy Drug Discovery Outsourcing estimated at US$900.8 Million in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 15.8% over the analysis period 2020-2027. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record a 15.2% CAGR and reach US$952.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunomodulators segment is readjusted to a revised 16.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $245.4 Million, While China is Forecast to Grow at 20.3% CAGR
The Cancer Immunotherapy Drug Discovery Outsourcing market in the U.S. is estimated at US$245.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$546.1 Million by the year 2027 trailing a CAGR of 20.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 14% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$371.3 Million by the year 2027.



Oncolytic Viral Therapies & Cancer Vaccines Segment to Record 15.9% CAGR
In the global Oncolytic Viral Therapies & Cancer Vaccines segment, USA, Canada, Japan, China and Europe will drive the 15.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$142.4 Million in the year 2020 will reach a projected size of US$378 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 17.6% CAGR through the analysis period.

SELECT PLAYERS

Aquila Biomedical; BPS Biosciences Inc.; Celentyx Ltd.; Covance, Inc.; Crown Bioscience Inc.; DiscoverX Corporation; Explicit Immuno-Oncology; Explicyte; Gen script Biotech Corporation; HD Biosciences Co. Ltd.; Horizon Discovery Group PLC; ImmunXperts SA; Molecular Imaging Inc. (MI Bioresearch Inc.); Personalis, Inc.; Promega Corporation; STC Biologics

SEGMENTS

» Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines, Other Drug Types) » Service Type (Target Identification & Validation, Lead Screening & Characterization, Cell-Based Assays) » Cancer Type (Lung, Breast, Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Cancer Immunotherapy Drug Discovery Outsourcing – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Immunomodulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Immunomodulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Immunomodulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oncolytic Viral Therapies & Cancer Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oncolytic Viral Therapies & Cancer Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncolytic Viral Therapies & Cancer Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Melanoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Melanoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Melanoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Target Identification & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Lead Screening & Characterization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Lead Screening & Characterization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lead Screening & Characterization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Cell-Based Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cell-Based Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cell-Based Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
JAPAN
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
CHINA
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
EUROPE
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
FRANCE
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
GERMANY
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
UNITED KINGDOM
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
AUSTRALIA
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
INDIA
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
LATIN AMERICA
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
MIDDLE EAST
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027
AFRICA
Cancer Immunotherapy Drug Discovery Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Other Cancer Types, Lung and Breast for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com